pandani.ai is a multidisciplinary team of technologists, clinician–scientists and healthcare professionals.

Our AI–driven diagnostic enrichment tools augment the expertise of clinicians and enhance organisational workflows.

Vision

We believe expertly crafted diagnostic tools enrich clinical experience, improve patient outcomes, and elevate the quality of care.

We place people at the heart of our approach to AI technology.

Our goal is to empower clinicians with automated tools that provide accurate insights and reduce workflow burdens. Our technologies are designed to support the pivotal role of the clinician in patient care.

AI diagnostics should be fast, simple to use, transparent in function, and immediately accessible. We are committed to integrating flexible solutions that seamlessly adapt to health system contexts.

We build our tools for impact, delivering precision, greater workplace satisfaction, and streamlined operations for clinicians and healthcare providers.

Research

A multi–resolution vision transformer model for skin cancer subtype classification using histopathology slides

29 January 2025

Digital pathology has significantly advanced cancer diagnosis by enabling high–resolution visualisation and assessment of tissue specimens. However, the manual analysis of these images remains labour–intensive and susceptible to human error, resulting in inconsistencies in diagnosis and treatment decisions.

We developed and externally validated a self–supervised, multi–resolution model for classifying the most common subtypes of skin cancer from whole slide images (WSIs). Our model demonstrates robust performance across diverse skin cancer subtypes, indicating a strong potential to assist anatomical pathologists in automatically detecting, highlighting, and classifying skin cancer subtypes directly from WSIs, and a subsequent capability to improve the effectiveness of clinical decision making. For non–melanoma cancer, our model can be deployed in regions with limited access to experienced dermatopathologists and a high incidence of the disease, particularly in low-resource settings.

Read the paper

A generalised vision transformer–based self–supervised model for diagnosing and grading prostate cancer using histological images

28 November 2024

Prostate cancer is the second most frequent carcinoma among men and a leading cause of morbidity and mortality. The gold standard for diagnosing and grading prostate cancer depends on a histopathological examination of prostate tissue biopsies, where the architectural pattern of the tissue and cellular morphology are assessed to assign a Gleason pattern score.

However, manual grading is labour–intensive, subjective, and susceptible to inter– and intra–observer variability, leading to diagnostic inconsistencies and compromised outcomes. These challenges highlight the need for developing more precise, objective, and reproducible cutting–edge tools in digital pathology.

Read the paper

People

Patrick Toohey

Founder, CEO

Pat is a technology executive and software engineer. He has spent the last two decades directing, developing, and scaling innovative solutions that drive measurable positive impact for people, communities, and organisations worldwide. Combining end-to-end technical expertise, strategic vision, and business leadership, he delivers transformative outcomes by integrating thoughtfully crafted technologies within industry and user contexts.

Contact Pat

Dr. Abadh Chaurasia

Founder, Principal Clinician–Scientist

Abadh is a clinician–scientist specialising in medical image analysis using Artificial Intelligence. His PhD in Medical Studies explored the integration of large image datasets and predictive modelling, highlighting the role of AI in early diagnosis and screening. Abadh is focused on developing advanced diagnostic and predictive models that significantly enhance clinical practice outcomes, particularly in low-resource settings.

Contact Abadh

Matthew Bennett

Founder, Business Development Director

An accomplished healthcare practitioner and entrepreneur, Matt has owned and directed high-turnover private practices for 25 years. With a background in applied health science, media, marketing, communications, and executive business management, Matt further brings significant expertise in overseeing the uniform adoption of diagnostic tools in medical service network settings.

Contact Matt

Dr. Alex Hewitt

Co-founder, Director

Alex is a distinguished clinician–scientist and NHMRC Leadership Fellow, renowned for his groundbreaking work in medical genetics. His research focuses on the application of cutting-edge technologies, including stem cell therapies, gene editing, and high-throughput AI-driven image analysis in medical diagnostics and treatment.

Contact Alex

Contact

Enquiries